Follow the people · Insider
Shannon T. Kelley
Shannon T. Kelley files insider transactions with the SEC as a general counsel of Madrigal Pharmaceuticals (MDGL). We hold 3 disclosed purchases and sales filed since 19 August 2024, 1 of them in the last 90 days.
- Files forMDGL
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure20 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 August 2024 — 17 August 2026General Counsel · Madrigal Pharmaceuticals (MDGL)25 Form 4 lines · source: SEC Form 4
Everything they disclosed
25 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 664 shares of Madrigal PharmaceuticalsSEC Form 420 August 2026Common Stock · traded 17 August 2026 · filed 20 August 2026
- was granted 4,017 shares of Madrigal PharmaceuticalsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 360 shares of Madrigal PharmaceuticalsSEC Form 46 March 2026Common Stock · traded 6 March 2026 · filed 6 March 2026
- was granted 5,022 shares of Madrigal Pharmaceuticals (a derivative holding)SEC Form 46 March 2026Stock Option (Right to Buy) · traded 4 March 2026 · filed 6 March 2026
- was granted 5,022 shares of Madrigal Pharmaceuticals (a derivative holding)SEC Form 46 March 2026Stock Option (Right to Buy) · traded 4 March 2026 · filed 6 March 2026
- was granted 4,017 shares of Madrigal PharmaceuticalsSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- ▼ sold on the open market 360 shares of Madrigal PharmaceuticalsSEC Form 46 March 2026Common Stock · traded 6 March 2026 · filed 6 March 2026
- ▼ sold on the open market 263 shares of Madrigal PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 20 January 2026 · filed 20 January 2026
- ▼ sold on the open market 429 shares of Madrigal PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 20 January 2026 · filed 20 January 2026
- ▼ sold on the open market 263 shares of Madrigal PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 20 January 2026 · filed 20 January 2026
- ▼ sold on the open market 429 shares of Madrigal PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 20 January 2026 · filed 20 January 2026
- ▼ sold on the open market 458 shares of Madrigal PharmaceuticalsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- ▼ sold on the open market 126 shares of Madrigal PharmaceuticalsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- ▼ sold on the open market 84 shares of Madrigal PharmaceuticalsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- ▼ sold on the open market 84 shares of Madrigal PharmaceuticalsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- ▼ sold on the open market 252 shares of Madrigal PharmaceuticalsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- ▼ sold on the open market 68 shares of Madrigal PharmaceuticalsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- ▼ sold on the open market 190 shares of Madrigal PharmaceuticalsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- ▼ sold on the open market 42 shares of Madrigal PharmaceuticalsSEC Form 418 August 2025Common Stock · traded 18 August 2025 · filed 18 August 2025
- was granted 5,368 shares of Madrigal Pharmaceuticals (a derivative holding)SEC Form 47 March 2025Stock Option (Right to Buy) · traded 5 March 2025 · filed 7 March 2025
- was granted 3,187 shares of Madrigal PharmaceuticalsSEC Form 47 March 2025Common Stock · traded 5 March 2025 · filed 7 March 2025
- ▼ sold on the open market 415 shares of Madrigal PharmaceuticalsSEC Form 45 March 2025Common Stock · traded 3 March 2025 · filed 5 March 2025
- ▼ sold on the open market 277 shares of Madrigal PharmaceuticalsSEC Form 417 January 2025Common Stock · traded 17 January 2025 · filed 17 January 2025
- was granted 7,820 shares of Madrigal Pharmaceuticals (a derivative holding)SEC Form 419 August 2024Stock Option (Right to Buy) · traded 15 August 2024 · filed 19 August 2024
- was granted 5,215 shares of Madrigal PharmaceuticalsSEC Form 419 August 2024Common Stock · traded 15 August 2024 · filed 19 August 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.